Engineering selective PI3Kγ inhibitors with antitumor and immunomodulatory potentials
PI3K γ represents a promising therapeutic target for its pivotal role in macrophage recruitment and polarization and its significant association with tumor invasion and metastasis. In this study, a series of novel indole-based PI3K γ selective inhibitors were generated by machine learning combined with molecular hybridization. Intriguingly, the representative IHA-5f displayed picomolar-level potency and highly selective inhibition to PI3K γ relative to PI3K α / β / δ . Moreover, IHA-5f manifested prominent anti-melanoma activity in vitro and in vivo with no detectable visceral toxicity. Mechanistically, IHA-5f efficiently suppressed tumor cell proliferation and migration, and induced apoptosis by suppressing the PI3K γ /AKT/NF- κ B signaling axis. Concurrently, it restrained the M2 polarization of tumor-associated macrophages, thereby augmenting the antitumor immune response. This study underscores the potential for PI3K γ inhibitors as immunomodulators and direct antitumor agents. PI3K γ -specific inhibitors were generated by machine learning combined with molecular hybridization, with representative IHA-5f exhibiting picomolar-level potency. Intriguingly, IHA-5f displayed excellent anti-melanoma effect via PI3K γ inhibition and TMA reprogramming.
Authors
- Yi Y. Zuo (ORCID: https://orcid.org/0000-0002-3992-3238)
- Maolin Wang (ORCID: https://orcid.org/0000-0001-7449-9834)
- Xinlan Li
- Jun Lü (ORCID: https://orcid.org/0000-0003-1625-8682)
- Yiru Pu
- Jin Liu (ORCID: https://orcid.org/0000-0002-1388-551X)
- Tingting Zhang (ORCID: https://orcid.org/0000-0002-4944-2323)
- Hongyu Chen (ORCID: https://orcid.org/0000-0002-9547-5417)
- Yao Chen (ORCID: https://orcid.org/0000-0001-7231-9860)
- Shilin Chen (ORCID: https://orcid.org/0000-0002-0449-236X)
- Jianan Liu (ORCID: https://orcid.org/0000-0001-5200-8125)
- Zhaotong Cong
- Yun Deng (ORCID: https://orcid.org/0000-0003-2802-2546)
- Hongbin Cheng
- Yan Wang (ORCID: https://orcid.org/0009-0002-3286-3516)
Institutions
- Hong Kong Baptist University (HK)
- Shenzhen University (CN)
- Shantou University (CN)
- First Affiliated Hospital of Shantou University Medical College (CN)
- Shenzhen University Health Science Center (CN)
- Chengdu University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Acta Pharmaceutica Sinica B
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1016/j.apsb.2025.11.011
- Citations
- 1
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81